Bevacizumab and Erlotinib in Lung Cancer With Brain Metastases, a Phase II Trial
Clinical trial NCT02655536 · UNKNOWN
Trial details
- NCT number
- NCT02655536
- Sponsor
- National Taiwan University Hospital
- Status
- UNKNOWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2017-08-01
- Primary completion
- 2019-06-01
- Enrollment
- 109
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.